![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
Study Shows Natera Test Faster than Imaging in Detecting Colorectal Cancer Recurrence
Natera’s Signatera test has shown potential in a newly-published survey for guiding treatment decisions after surgery by identifying colorectal cancer recurrence at an average...
RenalytixAI, UMCG to Partner on Kidney Disease Diagnostic Study
RenalytixAI will assess its lead product, the AI-enabled kidney disease diagnostic KidneyIntelX, in more than 3,500 patients with Type II diabetes through a collaboration...
Former Foundation Medicine Execs Join Hopkins Kimmel Directors, VCs in New Company
Steven Kafka, Ph.D., the former president and chief operating officer of Foundation Medicine who left the company last year, has joined with former colleagues...
Institut Curie, PrediLife Partner on Test for Breast Cancer Risk
PrediLife said it will carry out genetic analyses in connection with its MammoRisk personalized breast cancer screening test through a partnership with the Institut...
MDxHealth Presents Data Supporting Prostate Cancer Tests
MDxHealth has presented positive data designed to demonstrate the accuracy and decision-making value of its two prostate cancer tests, ConfirmMDx and SelectMDx.
The molecular diagnostics...
HTG, Illumina Expand IVD Test Collaboration to Autoimmune, CV, Fibrosis Disorders
HTG Molecular Diagnostics said today it has expanded a 4½-year-old agreement with Illumina allowing for development of in-vitro diagnostic (IVD) test kits for use...
Canopy Biosciences Expands into ‘Multi-Omics’ Company with Zellkraftwerk Acquisition
Canopy Biosciences, a provider of gene editing and gene expression products and services, has acquired Zellkraftwerk for an undisclosed price, in a deal designed...
Rady Researchers Use AI ‘Pipeline’ for Rapid Diagnosis of Rare Genetic Diseases
Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) have built an automated pipeline designed to deliver a potential diagnosis in record time for hospitalized...
Illumina Joins Children’s Hospital of Fudan University to Study Rapid WGS in NICU
Illumina said it has agreed with Children’s Hospital of Fudan University in Shanghai to conduct rapid whole genome sequencing (rWGS) in the hospital’s neonatal...
Genomics Medicine Ireland Opens Dublin Clinic for Precision Medicine Research
Genomics Medicine Ireland (GMI), the recently-acquired Irish subsidiary of WuXi NextCode, said today it has opened a research clinic in Dublin’s City Centre hub,...
